S&P 500

5.304,72

0,70%

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

Início
Investir
Ações
Canadá
TSXV
RepliCel Life Sciences Inc (RP)
RepliCel Life Sciences Inc (RP) Notícias

RP

RepliCel Life Sciences (RP)

RepliCel Life Sciences Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:TSXV:RP

1 2 3 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
08/05/2024	09:14	PR Newswire (Canada)	Suspension de la négociation par l'Organisme canadien de réglementation des investissements - RP	TSXV:RP	RepliCel Life Sciences Inc
08/05/2024	09:11	PR Newswire (Canada)	Canadian Investment Regulatory Organization Trading Halt - RP	TSXV:RP	RepliCel Life Sciences Inc
29/11/2023	01:48	PR Newswire (Canada)	TSX Venture Exchange Stock Maintenance Bulletins	TSXV:RP	RepliCel Life Sciences Inc
23/12/2019	08:00	PR Newswire (Canada)	RepliCel Announces its Incoming Board of Directors	TSXV:RP	RepliCel Life Sciences Inc
26/11/2019	08:00	PR Newswire (Canada)	RepliCel Provides 2019 Year-End Update	TSXV:RP	RepliCel Life Sciences Inc
24/09/2019	07:00	PR Newswire (Canada)	Clinical Data Published from RepliCel's Skin Rejuvenation Study	TSXV:RP	RepliCel Life Sciences Inc
10/09/2019	07:00	PR Newswire (Canada)	RepliCel's Partner, YOFOTO (China) Health, Unveils its Inaugural Cell Therapy Manufacturing Facility in China	TSXV:RP	RepliCel Life Sciences Inc
29/08/2019	07:00	PR Newswire (Canada)	RepliCel Life Sciences Retains Dermatology Sales and Marketing Executive to Guide the Global Commercial Strategy for its Auto...	TSXV:RP	RepliCel Life Sciences Inc
16/04/2019	07:00	PR Newswire (Canada)	RepliCel Secures Several New Patents for its Regenerative Medicine Technologies	TSXV:RP	RepliCel Life Sciences Inc
26/03/2019	07:00	PR Newswire (Canada)	RepliCel's Licensee Building Momentum in China with Facility and Team	TSXV:RP	RepliCel Life Sciences Inc
19/03/2019	07:00	PR Newswire (Canada)	RepliCel Reignites its First-in-Japan Strategy	TSXV:RP	RepliCel Life Sciences Inc
05/03/2019	08:00	PR Newswire (Canada)	RepliCel CEO Provides 2019 Shareholder Update	TSXV:RP	RepliCel Life Sciences Inc
06/11/2018	09:00	PR Newswire (Canada)	RepliCel Life Sciences Appoints Head of Clinical and Regulatory Affairs	TSXV:RP	RepliCel Life Sciences Inc
18/10/2018	07:00	PR Newswire (Canada)	RepliCel Announces Federal Grant Funding for Collaboration with the University of Victoria, Canada	TSXV:RP	RepliCel Life Sciences Inc
17/10/2018	07:00	PR Newswire (Canada)	RepliCel Life Sciences Appoints New Chief Financial Officer	TSXV:RP	RepliCel Life Sciences Inc
15/10/2018	07:00	PR Newswire (Canada)	RepliCel CEO Provides Updated Outlook	TSXV:RP	RepliCel Life Sciences Inc
11/10/2018	07:00	PR Newswire (Canada)	RepliCel Life Sciences Completes Financing with YOFOTO (China) Health	TSXV:RP	RepliCel Life Sciences Inc
24/09/2018	07:00	PR Newswire (Canada)	RepliCel Life Sciences and YOFOTO (China) Health Obtain All Approvals Needed to Complete Investment	TSXV:RP	RepliCel Life Sciences Inc
11/07/2018	07:00	PR Newswire (Canada)	RepliCel Life Sciences Announces Signed Licensing and Co-Development Deal for Greater China	TSXV:RP	RepliCel Life Sciences Inc
02/05/2018	07:00	PR Newswire (Canada)	RepliCel Life Sciences Now Finalizing its Strategic Investment Partnership with China-based YOFOTO	TSXV:RP	RepliCel Life Sciences Inc
25/01/2018	09:00	PR Newswire (Canada)	RepliCel CEO Provides 2018 Shareholder Update	TSXV:RP	RepliCel Life Sciences Inc
16/01/2018	09:00	PR Newswire (Canada)	RepliCel Life Sciences Lands Commitment for Key Investment Partnership	TSXV:RP	RepliCel Life Sciences Inc
19/10/2017	19:00	PR Newswire (Canada)	RepliCel Life Sciences Successfully Closes Financing	TSXV:RP	RepliCel Life Sciences Inc
22/09/2017	21:24	PR Newswire (Canada)	RepliCel Retains Hybrid Financial for Investor Relations	TSXV:RP	RepliCel Life Sciences Inc
13/09/2017	07:00	PR Newswire (Canada)	RepliCel's Partnership Initiatives Mature into Licensing Negotiations	TSXV:RP	RepliCel Life Sciences Inc
07/09/2017	07:00	PR Newswire (Canada)	RepliCel Showcases First Fully-Functional Prototypes of its Next-Generation Dermal Injector	TSXV:RP	RepliCel Life Sciences Inc
10/08/2017	07:00	PR Newswire (Canada)	Prominent Skin Aging Researcher Provides Insights into RepliCel's Clinical Data	TSXV:RP	RepliCel Life Sciences Inc
13/06/2017	07:00	PR Newswire (Canada)	RepliCel Collaborates with University of British Columbia to Build World-Class Hair Follicle Cell Data Map	TSXV:RP	RepliCel Life Sciences Inc
25/05/2017	07:00	PR Newswire (Canada)	RepliCel CEO Provides Company Outlook	TSXV:RP	RepliCel Life Sciences Inc
25/04/2017	07:00	PR Newswire (Canada)	United States Patent Issued to RepliCel for its Novel Dermal Injection Technologies	TSXV:RP	RepliCel Life Sciences Inc